Perrigo Co PLC (PRGO)

52.29 +0.48  +0.93% NYSE Dec 6, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/27/2020 16:30 EST Misc Perrigo Co PLC Fourth Quarter Earnings Conference Call in 2019
02/27/2020 Earnings Perrigo Co PLC Fourth Quarter Earnings in 2019 Release
11/27/2019 Dividends Amount: 0.21, Declared Date: Nov 04 2019, Pay Date: Dec 17 2019
11/06/2019 Earnings Perrigo Co PLC Third Quarter Earnings for 2019 Release
11/06/2019 08:00 EST Misc Perrigo Co PLC Third Quarter Earnings Conference Call for 2019
08/29/2019 Dividends Amount: 0.21, Declared Date: Jul 31 2019, Pay Date: Sep 17 2019
08/08/2019 08:00 EDT Misc Perrigo Co PLC Second Quarter Earnings Conference Call in 2019
08/08/2019 Earnings Perrigo Co PLC Second Quarter Earnings in 2019 Release
05/30/2019 Dividends Amount: 0.21, Declared Date: Apr 26 2019, Pay Date: Jun 18 2019
05/09/2019 08:00 EDT Misc Perrigo Co PLC First Quarter Earnings Conference Call in 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.perrigo.com
  • Investor Relations URL: http://perrigo.investorroom.com/
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Mid Cap/Value
  • Next Earnings Release: Feb. 27, 2020
  • Last Earnings Release: Nov. 06, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Nov. 27, 2019
  • Description: Perrigo is the leading provider of over-the-counter generic drugs with over 100 global locations. The company was formed in 1887 as a packager of home remedies and has grown with the migration of prescriptions switching to over the counter and later with strategic acquisitions. The company has a portfolio of more than 3,000 product formulations and 14,000 stock-keeping units. Most of its manufacturing and customer base reside in North America. With the most recent management change, the company announced a narrower focus on consumer wellness in conjunction with the divestiture of animal health, acquisition of Ranir Global Holdings, and plans to sell or spin off the prescription business.

Top Fund Holders

Symbol Name Weighting
PFPWX Parnassus Endeavor Institutional 4.42%
XPH SPDR® S&P Pharmaceuticals ETF 3.82%
PJP Invesco Dynamic Pharmaceuticals ETF 2.78%
PBE Invesco Dynamic Biotech & Genome ETF 2.78%
IHE iShares US Pharmaceuticals ETF 2.77%
TMCJX Touchstone Mid Cap C 2.49%
EAFRX First Eagle Fund of America R4 2.48%
RRMVX T. Rowe Price Mid-Cap Value R 2.13%
PPH VanEck Vectors Pharmaceutical ETF 1.74%
FMQSX Franklin Mutual Quest R 1.71%
DFTVX DFA US Targeted Value R1 0.47%
SIZE iShares Edge MSCI USA Size Factor ETF 0.18%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.